IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY

INTRODUCTION: Adoptive T cell immunotherapy (ACT) leads to extension of median survival and long-term cures of treatment-resistant models of malignant glioma, medulloblastoma, and pontine gliomas. While very promising, tailored strategies to overcome ACT failure are needed. Therefore, we studied the...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Wildes, Tyler, Dyson, Kyle, Grippin, Adam, DiVita, Bayli, Flores, Catherine, Mitchell, Duane
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216297/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.535
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料